Australia's CSL signs deals to manufacture two COVID-19 vaccine candidates

Sept 7 (Reuters) - Pharmaceutical company CSL Ltd said on Monday it had signed an agreement for the manufacture of an AstraZeneca and Oxford University COVID-19 vaccine, with first doses for Australia expected by early 2021 if trials prove successful.

The company said it signed another agreement with the Australian government to manufacture an alternative potential vaccine developed with the University of Queensland, with first doses of that vaccine expected by mid-2021. (Reporting by Rashmi Ashok in Bengaluru Editing by Sonya Hepinstall)


Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.

Sign up for a free trial of our full service at and follow us on Twitter @Breakingviews and at All opinions expressed are those of the authors.